These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


299 related items for PubMed ID: 19617723

  • 1. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.
    von Falck C, Rodt T, Joerdens S, Waldeck S, Kiesel H, Knapp WH, Galanski M.
    Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
    Potter KC, Husband JE, Houghton SL, Thomas K, Brown G.
    Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
    [Abstract] [Full Text] [Related]

  • 3. Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging.
    Dong Q, Wong KK, Avram AM.
    Clin Nucl Med; 2008 Jan; 33(1):30-1. PubMed ID: 18097253
    [Abstract] [Full Text] [Related]

  • 4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 5. Sciatic nerve neurolymphomatosis - extent and therapy response assessment with PET/CT.
    Strobel K, Fischer K, Hany TF, Poryazova R, Jung HH.
    Clin Nucl Med; 2007 Aug; 32(8):646-8. PubMed ID: 17667443
    [Abstract] [Full Text] [Related]

  • 6. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R.
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [Abstract] [Full Text] [Related]

  • 7. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ, Zhang YX, Wei H, Jia Q.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2253-6. PubMed ID: 18001544
    [Abstract] [Full Text] [Related]

  • 8. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
    Karantanis D, O'Neill BP, Subramaniam RM, Peller PJ, Witte RJ, Mullan BP, Wiseman GA.
    Clin Nucl Med; 2007 Apr 28; 32(4):271-4. PubMed ID: 17413571
    [Abstract] [Full Text] [Related]

  • 9. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
    Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, Fillet G.
    Haematologica; 2001 Mar 28; 86(3):266-73. PubMed ID: 11255273
    [Abstract] [Full Text] [Related]

  • 10. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2007 Oct 28; 43(9):887-93. PubMed ID: 17207656
    [Abstract] [Full Text] [Related]

  • 11. Fat necrosis mimicking B-cell lymphoma: a PET/CT and FDG study.
    Belakhlef A, Jani C, Church C, Fraser R, Lakhanpal S.
    Clin Nucl Med; 2008 Apr 28; 33(4):271-2. PubMed ID: 18356666
    [Abstract] [Full Text] [Related]

  • 12. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.
    Ann Surg; 2007 Dec 28; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [Abstract] [Full Text] [Related]

  • 13. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
    Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, Moser E, Glatting G, Kotzerke J, Guhlmann CA, Schirrmeister H, Reske SN.
    Cancer; 2001 Mar 01; 91(5):889-99. PubMed ID: 11251940
    [Abstract] [Full Text] [Related]

  • 14. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
    Tateishi U, Hosono A, Makimoto A, Nakamoto Y, Kaneta T, Fukuda H, Murakami K, Terauchi T, Suga T, Inoue T, Kim EE.
    Ann Nucl Med; 2009 Feb 01; 23(2):155-61. PubMed ID: 19225939
    [Abstract] [Full Text] [Related]

  • 15. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U, Even-Sapir E.
    Semin Nucl Med; 2007 May 01; 37(3):206-22. PubMed ID: 17418153
    [Abstract] [Full Text] [Related]

  • 16. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
    Basu D, Siegel BA, McDonald DJ, Nussenbaum B.
    Arch Otolaryngol Head Neck Surg; 2007 Aug 01; 133(8):801-5. PubMed ID: 17709620
    [Abstract] [Full Text] [Related]

  • 17. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.
    Flamen P, Lerut A, Van Cutsem E, Cambier JP, Maes A, De Wever W, Peeters M, De Leyn P, Van Raemdonck D, Mortelmans L.
    J Thorac Cardiovasc Surg; 2000 Dec 01; 120(6):1085-92. PubMed ID: 11088030
    [Abstract] [Full Text] [Related]

  • 18. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.
    Liu FY, Yen TC, Chen MY, Lai CH, Chang TC, Chou HH, Hong JH, Chen YR, Ng KK.
    Cancer; 2009 Dec 01; 115(23):5470-80. PubMed ID: 19739235
    [Abstract] [Full Text] [Related]

  • 19. Neurolymphomatosis detected by (18)F-FDG PET/CT scan - a case report.
    Czepczyński R, Guzikowska-Ruszkowska I, Sowiński J.
    Nucl Med Rev Cent East Eur; 2008 Dec 01; 11(2):73-5. PubMed ID: 19585459
    [Abstract] [Full Text] [Related]

  • 20. Magnetic resonance imaging of malignant lymphoma.
    Vermoolen MA, Kersten MJ, Fijnheer R, van Leeuwen MS, Kwee TC, Nievelstein RA.
    Expert Rev Hematol; 2011 Apr 01; 4(2):161-71. PubMed ID: 21495926
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.